Erythromycin is a potent inhibitor of bacterial protein synthesis, and is thought to act by sterically hindering growth of the nascent peptide chain (Vazquez, 1979) . The binding site for erythromycin is located on the large ribosomal subunit in the vicinity of the peptidyl transferase center. Most of the rRNA nucleotide alterations that cause erythromycin resistance are point mutations and base methylation within the central loop of domain V of the 23 S rRNA (for reviews see Weisblum, 1995; Garrett & Rodriguez-Fonseca, 1995 ; and see Figure 1 ). Several nucleotides in this region are protected by erythromycin from chemical modification (Moazed & Noller, 1987) . This internal loop in domain V of the 23 S rRNA thus appears to be the primary binding site for erythromycin.
It was therefore surprising that a mutation in another region of the 23 S rRNA was also shown to confer erythromycin resistance (Douthwaite et al., 1985) . Deletion of 12 nucleotides (positions 1219-1230) within a conserved rRNA hairpin structure between nucleotides 1198 and 1247 (the 1200-1250 helix) in domain II of the Escherichia coli 23 S rRNA gene, increased the minimal concentration of erythromycin required to inhibit cell growth three to four times. Other engineered deletions in this region produced similar effects (Douthwaite et al., 1989) . Curiously, however, these deletions did not affect binding of erythromycin to the mutant ribosomes, as assayed by footprinting in vitro (Douthwaite et al., 1989) . This contrasts with a marked reduction in the ribosome-drug interaction caused by point mutations at the central loop in domain V (Douthwaite & Aagaard, 1993 (Noller, 1984; Gutell et al., 1994) . The 1200-1250 hairpin in domain II is shown in bold.
mutations disrupted a functional interaction between domains II and V, and thereby suppressed the action of the drug without preventing its binding. However, these observations can now be reinterpreted in the light of new data.
Recently, a novel type of erythromycin resistance has been proposed, the mechanism of which is based on interaction between a specific pentapeptide and the ribosome (Tenson & Mankin, 1995; Tenson et al., 1996) . This peptide (the E-peptide) is encoded in a short open reading frame (ORF) between nucleotides 1248 and 1265 at the junction of domains II and III within the E. coli 23 S rRNA (Figure 2) . A putative Shine-Dalgarno region (S.-D.; Shine & Dalgarno, 1974) for the E-peptide ORF is located at the adjacent sequence 1235 to 1240. The proximity of this ORF to the position of the domain II deletions suggests that resistance to erythromycin might be acquired, owing to enhanced expression of the E-peptide. Here we present data on a range of point mutations that have been introduced into the 1200-1250 helix. These mutations reduce the stability of the helix and render the putative S.-D. sequence more accessible. By correlating the accessibility of the S.-D. sequence with cell resistance to erythromycin, we are able to test the E-peptide hypothesis.
Effects of helix 1200 to 1250 mutations in intact 23 S rRNA
The E-peptide ORF has a canonical S.-D. sequence. ln the intact 23 S rRNA, this S.-D. sequence is a part of the 1200-1250 hairpin structure (Figures 1 and 2; and Noller, 1984) , and is presumably unavailable to serve as a ribosome binding site for initiation of translation. Nucleotide substitutions were generated in the 1200 to 1250 hairpin to investigate whether altering the stability of the hairpin gives rise to erythromycin resistance. The mutant 23 S rRNAs were expressed in vivo from the multicopy plasmid pLK55, which contains a complete rRNA operon under the control of the lambda P L promoter. Some of the point mutations notably increased cell tolerance to erythromycin (Table 1) . To rationalize the effects of individual mutations, the stability of the 1200-1250 hairpin in the mutant 23 S rRNAs was calculated. These results are presented in Table 1 , and some of the representative secondary structures are shown in Figure 2 .
The data reveal a strong inverse correlation between the stability of the 1200-1250 hairpin and the drug resistance of cells. Out of 35 analyzed mutants only two, pLK55-130 and −136, do not follow this general rule. Mutants 130 and 136 are erythromycin-sensitive, although the over-all stability of the mutant hairpin is weakened (DG = −8.9 and −6.5 kcal/mol, respectively, compared to −15.4 kcal/mol for the wild-type helix). However, the 1206A mutation present in these mutants directly stabilizes the interaction between the S.-D. sequence and the opposite side of the hairpin, so that weakening of the apex part of the hairpin may be not sufficient to release the S.-D. region ( Figure 3 ). In addition, the 1236A mutation in pLK55-136 changes the actual S.-D. sequence, reducing its complementarity to the 3' end of 16 S rRNA.
Several mutants carry a 1248A mutation, which changes the rarely used initiation GUG codon of the E-peptide ORF to the prevailing initiator codon AUG (Table 1 ). The change of initiator codon alone is not sufficient to significantly increase expression of the E-peptide, since mutant 11, having only the 1248A mutation, remains erythromycin-sensitive. However, enhanced drug resistance is observed when the AUG initiator codon occurs in combination with mutations that increase the accessibility of the S.-D. region (mutant 48, Figure 2 ). The pLK55-48 construct exhibits the highest level of erythromycin resistance of all the point mutants analyzed (Table 1) . Hence, mutations that may increase expression of the rRNA-encoded E-peptide result in an Ery r phenotype, while those mutations that would either reduce or leave the peptide expression significantly unchanged do not confer drug resistance.
A similar trend emerges on examination of deletion mutations that also affect the hairpin stability (Douthwaite et al., 1989) . Comparison of the secondary structure in these mutants with the wild-type hairpin structure is more complicated, because in many cases the deletions will cause an Mutations were generated in a 1 kb SacI-SalI fragment of the 23 S rRNA gene sub-cloned into bacteriophage M13. DNA heteroduplexes were formed in a manner similar to that described by Rosendahl & Douthwaite (1995) , creating a single-stranded window at the sequence from 1197 to 1248. Mutations were introduced by bisulfite deamination of cytosine residues in the single-stranded window (Pine & Huang, 1987) . Both strands of the gene fragment were mutagenized to give G : A as well as C : U transitions. SacI-SalI fragments were cloned back into their original rrnB context for expression from the lambda PL promoter in pLK55. Plasmid pLK55 is essentially identical to pLK35 (described by Douthwaite et al., 1989) but contains a phenotypically neutral allele-specific priming site around 23 S rRNA position 1360 (Aagaard et al., 1991) . Plasmids pLK35 and pLK55 are pBR322 derivatives containing the entire E. coli rrnB operon under control of the lambda PL promoter (Gourse et al., 1985) . Plasmids were propagated in the E. coli strain DH1 (Sambrook et al., 1989) for which minimal inhibitory concentration of erythromycin was 25 mg/ml. b Phenotype of the mutants was determined by plating on agar containing ampicillin at 25 mg/ml and different concentrations of erythromycin. S, erythromycin-sensitive mutants; R35, R50 and R80, mutants capable of growing in the presence of 35 mg/ml, 50 mg/ml and 80 mg/ml erythromycin, respectively.
c Stability of the wild-type and mutant hairpins (kcal/mol) was determined using energy minimization program (Zuker, 1994 ) provided on M. Zuker's world wide web homepage (http://ibc.wustl.edu/ 0zuker/cgi-bin/form1.cgi).
alternative folding of this RNA region. Nevertheless, there is generally a good correlation between accessibility of the S.-D. region of the E-peptide ORF and erythromycin resistance of the mutant. Small deletions that have little effect on hairpin stability do not induce erythromycin resistance (e.g. mutants D1223-1226 in Figure 2 ). However, a similar size deletion, which weakens the hairpin (mutant D1231-1234), produces an Ery r phenotype. Removal of more than four nucleotides significantly destabilizes the hairpin. Thus, mutants lacking 4 to 11 nucleotides to the 3' side from position 1229 are erythromycin-resistant (for example, mutants D1229-1234 and D1229-1236 in Figure 2 ). Longer deletions on this side of the helix (12 or more nucleotides 3' to position 1229) start to remove the S.-D. sequence resulting in loss of resistance. Deletions of 9 to 17 nucleotides 5' to the position 1232 destabilize the hairpin, while leaving the S.-D. sequence intact and also confer drug resistance. All these observations are completely consistent with the prediction that an accessible S.-D. sequence is required for translation of the E-peptide. However, it is not immediately obvious why mutants carrying 23 S rRNA lacking 17 to 24 nucleotides 5' to the position 1232 are not resistant to erythromycin. ) were grown overnight in LB medium containing ampicillin at 100 mg/ml. Samples (50 ml) of overnight cultures were inoculated into 2 ml LB medium containing ampicillin at 100 mg/ml, 1 mM IPTG and different concentration of erythromycin. Cultures were grown for 3.5 hours at 37°C with constant shaking, and the absorbance was measured at 600 nm. (Tenson et al., 1996) , where they were expressed from the tac promoter. Wild-type and mutant rRNA fragments were expressed in approximately the same amounts as revealed by Northern blotting. All the plasmids were propagated in JM109 cells (Sambrook et al., 1989) . Samples (10 ml) of overnight cultures were inoculated into 2 ml LB medium containing 100 mg/ml ampicillin and 1 mM IPTG with or without 100 mg/ml erythromycin. (Minimal inhibitory concentration of erythromycin for untransformed E. coli JM109 cells was 150 mg/ml). Cultures were grown for five hours at 37°C, and their absorbance at 600 nm was measured. Growth of the cells in the presence of erythromycin was normalized according to their growth in the absence of erythromycin.
Possibly, the mutant rRNA folds up differently and prevents access to the E-peptide ORF S.-D. or, alternatively, these deletions could enhance degradation of the rRNA. In spite of these exceptions, the effects of the majority of Ery r point mutations and deletions can be explained by weakening the hairpin structure and making the S.-D. region of the E-peptide ORF more accessible.
Small rRNA fragments derived from mutant 23 S rRNA can confer erythromycin resistance
The mechanism of erythromycin resistance conferred by domain II mutations was originally thought to involve a change in the 23 S rRNA function within the ribosome (Douthwaite et al., 1985) . If this were the case, intact mutant 23 S rRNA would be required for assembly into functionally active ribosomes. However, if our new model is correct and the Ery r effect of domain II mutations is mediated by translation of the E-peptide, the presence of the intact mutant 23 S rRNA would be unnecessary, and smaller rRNA fragments should be sufficient to confer resistance.
As the first step to discriminating between the two models, the erythromycin tolerance of cells expressing the wild-type 23 S rRNA fragment 1192-1305 (containing the complete 1200-1250 hairpin) was compared with the tolerance of cells expressing the fragment 1235-1276 where only 3' strand of the hairpin was present. These rRNA gene fragments were PCR amplified from the E. coli rrnB operon and introduced into the pPOT1 vector, where they were expressed under the control of IPTG-inducible tac promoter (Tenson et al., 1996) . The cells expressing the 1235-1276 rRNA fragment exhibited significantly lower resistance to erythromycin compared to the cells expressing 1192-1305 fragment (Figure 3 ). This again indicates that expression of the E-peptide is prevented when the 1200-1250 hairpin remains intact.
Next, gene fragments of the mutant 23 S rRNAs, containing the entire 1200-1250 hairpin and E-peptide ORF, were expressed in vivo from the tac promoter of the pPOT1 vector (Tenson et al., 1996) . Cell growth in the presence of subinhibitory concentrations of erythromycin was measured. For the five mutations tested, a close correlation was observed between their ability to confer erythromycin resistance when expressed in the context of intact 23 S RNA and in the context of small rRNA fragments (Figure 4) . These results demonstrate that the resistance determinant in the tested mutants is confined to the 23 S rRNA region containing the 1200-1250 hairpin and the adjacent E-peptide ORF, and thus provides further support to the hypothesis that erythromycin resistance is mediated by an increased expression of the E-peptide.
Conclusions
23 S RNA domain II deletions and point mutations that confer erythromycin resistance do so by a completely different mechanism than other Ery r mutations located at the drug binding site in domain V. Ery r mutations in domain II affect the stability of a hairpin in which the S.-D. region of the rRNA-encoded E-peptide ORF is sequestered. Since accumulation of the E-peptide affords erythromycin resistance (Tenson & Mankin, 1995; Tenson et al., 1996) , it is most probable that the effect of Ery r mutations in domain II is to mediate activation of expression of the E-peptide, which is apparently not translated from the intact wild-type 23 S rRNA. Furthermore, it is possible that the peptide-mediated mechanism of erythromycin resistance accounts for Ery r phenotypes of some clinical bacterial isolates.
